US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 12, 2021 (5 years ago)

dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-951-01.

Recalling firm
SterRx, LLC
NDC code
70324-951-01
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0315-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Diltiazem recalls

See all